DCA Unearths Spurious Medicine Racket In Vijayawada

Vijaywada : The Department of Drugs Control Administration of the State government has busted a spurious drug racket in Vijayawada.

The Drugs Inspector has established that certain drugs manufactured by reputed pharma companies are imitated, and manufactured in a manner that would deceive unsuspecting consumers. The department further learnt that the unauthorised dealers are supplying substandard medicines by falsely labelling them as products manufactured by a reputed pharma company.

These counterfeit and spurious drugs would cause severe and fatal damage to one’s health as they are not manufactured by the original drug companies. The materials used in the drugs and the conditions being maintained at the manufacturing facility are of dubious quality, and it is likely that the ingredients can be toxic and can even cause death, said B. Anvesh Reddy, Drugs Inspector, Vijayawada Zone-IV of the Drug Control Administration in his complaint lodged with the Bhavanipuram police in Vijayawada on September 6 (Wednesday). The Hindu has accessed the complaint of the Drugs Inspector, a copy of the First Information Report (FIR) and other laboratory findings related to the drug racket.

The FIR has been registered against P.D.M.K.R.G. Krishna Murthy, of Lakshmi Padmavathi Pharma at Vasavi Pharma Market Complex in Vijayawada, and N. Kiran Kumar of Vidyadharapuram in Vijayawada under Sections 420 (cheating and dishonestly inducing delivery of property), 471 (using as genuine a forged document), 274 (adulteration of drugs) and 275 (selling adulterated drugs) of the Indian Penal Code (IPC).

Related Posts

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

GUWAHATI: Indian Institute of Technology Guwahati researchers have developed an optical sensing device that can instantly detect a variety of toxicants in water and other biological samples. Aligned with the Government…

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad